Get the latest Science News and Discoveries
Biomarkers of nivolumab benefit in resectable non-small cell lung cancer
Potential predictive biomarkers of perioperative nivolumab therapy benefit in non-small cell lung cancer are identified from evaluable participants in the CheckMate 77T trial.
None
Or read this on Nature